Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 11:9:867147.
doi: 10.3389/fmed.2022.867147. eCollection 2022.

Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies

Affiliations
Review

Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies

Sebastian Millen et al. Front Med (Lausanne). .

Abstract

Breastfeeding is recommended by the World Health Organization for at least 6 months up to 2 years of age, and breast milk protects against several diseases and infections. Intriguingly, few viruses are transmitted via breastfeeding including Human T-cell leukemia virus Type 1 (HTLV-1). HTLV-1 is a highly oncogenic yet neglected retrovirus, which primarily infects CD4+ T-cells in vivo and causes incurable diseases like HTLV-1-associated inflammatory conditions or Adult T-cell leukemia/lymphoma (ATLL) after lifelong viral persistence. Worldwide, at least 5-10 million people are HTLV-1-infected and most of them are unaware of their infection posing the risk of silent transmissions. HTLV-1 is transmitted via cell-containing body fluids such as blood products, semen, and breast milk, which constitutes the major route of mother-to-child transmission (MTCT). Risk of transmission increases with the duration of breastfeeding, however, abstinence from breastfeeding as it is recommended in some endemic countries is not an option in resource-limited settings or underrepresented areas and populations. Despite significant progress in understanding details of HTLV-1 cell-to-cell transmission, it is still not fully understood, which cells in which organs get infected via the oral route, how these cells get infected, how breast milk affects this route of infection and how to inhibit oral transmission despite breastfeeding, which is an urgent need especially in underrepresented areas of the world. Here, we review these questions and provide an outlook how future research could help to uncover prevention strategies that might ultimately allow infants to benefit from breastfeeding while reducing the risk of HTLV-1 transmission.

Keywords: HTLV-1; breast milk; breastfeeding; oral route; small intestine; tonsils; virus transmission.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The dilemma of breastfeeding and HTLV-1 transmission. HCMV, Human Cytomegalovirus; HIV, Human Immunodeficiency virus; HTLV, Human T-cell leukemia virus; WHO, World Health Organization. Created with BioRender.
FIGURE 2
FIGURE 2
The oral route of HTLV-1 transmission. HTLV-1 is transmitted from mother to child via breastfeeding. It remains to be determined (1) whether HTLV-1 or HTLV-1-infected cells cross epithelial barriers in the tonsils, the stomach, or the intestine of the infant in vivo, and (2) by which mechanisms the virus is transmitted in vivo. Tissues and cells displayed in this figure were drawn manually by Annika P. Schnell with Procreate® Version 5.2.4 (Hobart, Tasmania) on the Apple iPad Pro 11” 2020 (Cupertino, United States).

Similar articles

Cited by

References

    1. Martin F, Tagaya Y, Gallo R. Time to eradicate HTLV-1: an open letter to WHO. Lancet. (2018) 391:1893–4. 10.1016/S0140-6736(18)30974-7 - DOI - PubMed
    1. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. (2012) 3:388. 10.3389/fmicb.2012.00388 - DOI - PMC - PubMed
    1. Rosadas C, Menezes MLB, Galvao-Castro B, Assone T, Miranda AE, Aragon MG, et al. Blocking HTLV-1/2 silent transmission in Brazil: current public health policies and proposal for additional strategies. PLoS Negl Trop Dis. (2021) 15:e0009717. 10.1371/journal.pntd.0009717 - DOI - PMC - PubMed
    1. Rosadas C, Assone T, Yamashita M, Adonis A, Puccioni-Sohler M, Santos M, et al. Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: the impact of a neglected disease on the quality of life. PLoS Negl Trop Dis. (2020) 14:e0008761. 10.1371/journal.pntd.0008761., - DOI - PMC - PubMed
    1. Rosadas C, Taylor GP. HTLV-1 and co-infections. Front Med. (2022) 9:812016. 10.3389/fmed.2022.812016 - DOI - PMC - PubMed